Targeting ACLY efficiently inhibits SARS-CoV-2 replication
Terrence Tsz‐Tai Yuen(Sichuan University), Hin Chu(University of Hong Kong), Chaemin Yoon(University of Hong Kong), Feifei Yin(Chinese Academy of Sciences), Yue Chai(Chinese University of Hong Kong), Shuofeng Yuan(University of Hong Kong - Shenzhen Hospital), Tianrenzheng Zhu(University of Hong Kong), Bingjie Hu(Wenzhou Medical University), Huiping Shuai(University of Hong Kong), Jasper Fuk‐Woo Chan(Hong Kong Science and Technology Parks Corporation), Jie Zhou(Chinese University of Hong Kong), Xiner Huang(University of Hong Kong), Yuxin Hou(University of Hong Kong), Cynthia Cheuk-Ying Shum(University of Hong Kong), Jian‐Piao Cai(University of Hong Kong), Jialu Shi(University of Hong Kong), Huan Liu(University of Hong Kong), Jinjin Zhang(Beihua University), Bao‐Zhong Zhang(Daqing Oilfield General Hospital), Bingpeng Yan(Hong Kong Science and Technology Parks Corporation), Jinxia Zhang(Peking University), Yuanchen Liu(University of Hong Kong)
Cited by 12
Related Papers
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
|The Lancet|2020|9.6k
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
|The Lancet Infectious Diseases|2020|3.4k
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
|Emerging Microbes & Infections|2020|3.3k
Consistent Detection of 2019 Novel Coronavirus in Saliva
|Clinical Infectious Diseases|2020|2k